Genomes and Genes

Species

Chong an Xu

Summary

Country: China

Publications

  1. Xu C, Chang Z, Wang X, Li L, Qi H, Liu Y. [A meta analysis of doublets versus single-agent chemotherapy for elderly patients with advanced non-small cell lung cancer]. Zhongguo Fei Ai Za Zhi. 2012;15:361-8 pubmed publisher
    ..However, further prospective randomized controlled trials in elderly NSCLC patients is needed to verify the findings in this study. ..
  2. Xu C, Liu J, Xing L, Liu S. [Clinical significance of serum cytokeratin 19 fragment in the prediction of chemotherapy efficacy and prognosis in patients with advanced non-small cell lung cancer]. Zhongguo Fei Ai Za Zhi. 2010;13:954-61 pubmed publisher
  3. Xu C, Gao Y, Li L, Xing L, Liu S. [Impact of anemia on chemotherapy efficacy and prognosis in patients with advanced non-small cell lung cancer]. Zhongguo Fei Ai Za Zhi. 2010;13:968-74 pubmed publisher
    ..NSCLC patients with anemia had lower QOL and chemotherapy efficacy, and shorter lifetime. Anemia was an independent prognostic factor in NSCLC patients. ..
  4. Xu C, Feng D, Li L, Yu P, Hu X, Liu Y. [The expression and prognostic significance of ERCC1 and GST-pi in lung cancer]. Zhongguo Fei Ai Za Zhi. 2010;13:195-200 pubmed publisher
    ..The positive expression of ERCC1 have better survival and may have effect on prognosis. ..
  5. Zhang X, Ma Y, Sun Y, Cao Y, Li Q, Xu C. Gemcitabine in Combination with a Second Cytotoxic Agent in the First-Line Treatment of Locally Advanced or Metastatic Pancreatic Cancer: a Systematic Review and Meta-Analysis. Target Oncol. 2017;12:309-321 pubmed publisher